✦ LIBER ✦

PIN33 COST EFFECTIVENESS OF SWITCHING TO SECOND LINE THERAPY WITH LOPINAVIR/RITONAVIR (LPV/R) IN KENYA

✍ Scribed by KN Simpson; B Dietz; S Rahim; R Rajagopalan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Economics of Switching to Second-Line An

✍ Kit N. Simpson; Robert W. Baran; Stephanie E. Kirbach; Birgitta Dietz 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 736 KB

PIN3 PREDICTORS OF EFFECTIVENESS WITH LO

✍ RF Yen; R Wattal; SS Sansgiry; L Sudharshan; S Yost; C Mayberry; M Ceperley; S R 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PIN65 Cost-Effectiveness of First-Line A

✍ J. Moller; K. Desai; K.N. Simpson; R. Baran; B. Dietz; O. Van de Steen 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PIN38: COST-EFFECTIVENESS OF LOPINAVIR/R

✍ MP Luo; MF Botteman; O Grad; MA Cifaldi; T Ashraf 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PIN37 Cost-Effectiveness of Treatment In

✍ Verheggen, B.; Aldir, I.; Tan, C.; Carrasco, J.; Antunes, A.; Lescrauwaet, B. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Short and Long-Term Cost-Effectiveness o

✍ Malek, R.; Gálvez, G.G.; Hammerby, E.; Nikolajsen, A.; Henriksen, O.; Andersen, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB